View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
November 26, 2021

Novacyt’s Covid-19 PCR test receives approval in UK

The genesig Covid-19 real-time PCR test is designed to target the ORF1ab gene.

The UK Health Security Agency has approved Novacyt’s genesig Covid-19 real-time PCR test under its Medical Devices (Coronavirus Test Device Approvals) (Amendment) Regulations 2021 (CTDA).

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

Introduced on 31 January last year, the assay is claimed to be the company’s first test to be added to the CTDA register.

The genesig Covid-19 assay is designed to target the ORF1ab gene and has the potential to detect all known Covid-19 variants and mutations.

The test has analysed more than 4.5 million sequences as mentioned in the company’s latest weekly bioinformatic surveillance report.

Novacyt Group CEO David Allmond said: “I am delighted to announce that our genesig Covid-19 test has become the seventh product to be approved and added to the CTDA register.

“With the associated resumption of the sale of this product in the UK, we look forward to ensuring our customers continue to have access to this market leading test during the winter season.

“Our genesig Covid-19 test was launched in late January 2020 and is recognised globally by leading public health bodies, including the US FDA, alongside long-term agreements with both UNICEF and the World Health Organization.”

The company has submitted 11 products for review under the CTDA legislation as announced earlier this month.

Novacyt stated that the PROmate Covid-19 test of its business unit Primerdesign is on the temporary protocol and is being supplied under the PHE National Microbiology Framework to the NHS.

In June this year, the company announced plans to launch two PathFlow COVID-19 antigen lateral flow tests (LFTs) to strengthen its Covid-19 portfolio.

Related Companies

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network